Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Erythritol Powder and Locally Derived Metronidazole for the Non-surgical Treatment of Peri-implant Mucositis and Peri-implantitis.

NCT02023853 is registered in ClinicalTrials.gov with Proed, Torino, Italy as lead sponsor.

NCT NCT02023853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02023853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Erythritol Powder and Locally Derived Metronidazole for the Non-surgical Treatment of Peri-implant Mucositis and Peri-implantitis.
Lead sponsor
Proed, Torino, Italy
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2013
Completion date
December 31, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peri-implantitis and peri-implant mucositis